Agreement - May 28, 2015
CEO: No Interest in Selling Firm
Despite Bavarian Nordic’s recent successes forging deals with major companies and attractiveness to larger firms, there are no plans to sell the company, says CEO Paul Chaplin in a FierceBiotech article. “You can’t stop interest if there is interest, but it’s not our ambition to sell the company,” Chaplin told Reuters. “Our end goal is not to sell to Big Pharma as […]
Uncategorized - May 27, 2015
Fish Vaccine Grant Issued
The research collaboration “New Targeting Vaccines for Sustainable Aquaculture” has received a grant of NOK 10 million through the Norwegian Research Council’s program Biotek2021. The NOK 10 million will be awarded over three years. Oslo Cancer Cluster member Vaccibody is a partner in the project with the Norwegian Veterinary Institute, Pharmaq AS, Kjeller Innovasjon and […]
Collaboration - May 27, 2015
Amgen, AZ End Psoriasis Drug Deal
Amgen is dissolving an agreement with AstraZeneca to develop the psoriasis drug brodalumab after a patient involved in a late-stage trial developed suicidal thoughts and behavior, according to BioSpace.com. Because of that incident, if the drug were eventually approved by regulators, they would likely require restrictive labeling, which discouraged Amgen. The latest news came as […]
Uncategorized - May 26, 2015
Too Many Painkillers Can Make Headaches Worse
A recent study has demonstrated that people with chronic headaches who take too many painkillers only make their pain worse, and that can lead to depression and anxiety. “This is really important,” says associate professor and lead author Lars Bendtsen of the Department of Clinical Medicine at Copenhagen University and the Danish Headache Centre at […]
Uncategorized - May 23, 2015
Risks of High Vitamin D Levels
In a study involving almost 250,000 people, scientists have found a connection between high levels of vitamin D in the blood and the risk of suffering a stroke or a coronary thrombosis, according to a ScienceNordic article. The findings cannot directly link the two, because it was an observational study. But the study results should […]
Companies - May 20, 2015
FDA Investigating Type 2 Diabetes Drugs
The U.S. Food and Drug Administration (FDA) is investigating diabetes drugs used to treat Type 2 diabetes made by Johnson & Johnson, AstraZeneca PLC and Eli Lilly and Company after 20 cases of ketoacidosis that required hospitalization were reported, according to BioSpace.com. Sodium-glucose cotransporter-2 (SGLT2) inhibitors used to treat type 2 diabetes may lead to […]
